0
Deep & Emerging Tech·June 23, 2026·1 min read

Astral Systems raises £23M to make cancer isotopes by fusion

Share

Fusion moving from “future grid” to “current isotope supply” is a reminder that deep tech can monetize on narrow, high-value niches long before it touches the power market. If you’re backing or building in fusion or adjacent fields, look for these interim industrial and medical revenue paths, not just the energy endgame.